Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8594835 | Journal of Stroke and Cerebrovascular Diseases | 2018 | 7 Pages |
Abstract
This study shows that patients who have off-label underdosing of DOACs do not develop more severe stroke and a poorer outcome than those with the recommended dose. Careful attention to recommended doses is required for the full benefits from DOACs.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Yuji MD, PhD, Takeshi MD, PhD, Norio MD, PhD, Masaki MD, PhD,